ChinaBio Therapeutics

ChinaBio Therapeutics

ChinaBio™ Therapeutics, Inc. (ChinaBio) is a near-virtual U.S.-based drug development company with headquarters in California and R&D operations planned in Suzhou, China, near Shanghai. ChinaBio’s business model is to in-license early stage drug candidates from the West, move them to human proof-of-concept in China, then out-license the drugs to major pharma or biotechs or spin them out to VC-backed ventures.

Scroll to top